ApexBrasil Boosts Brazilian Exports and Investment Links with Europe Through New Digital Tool and Global Biohealth Presence
ApexBrasil has launched a new tool to aid Brazilian exporters entering the EU market and highlighted Brazil’s biotech sector at the 2026 BIO International Convention, expanding international business and investment opportunities.
- • ApexBrasil launched a new tool mapping 543 export opportunities with reduced tariffs across 25 EU countries.
- • The tool helps micro, small, and medium-sized Brazilian companies identify export potentials by state.
- • Brazil showcased its biotech and pharmaceutical sectors at BIO International Convention 2026, with over 70 companies participating.
- • These initiatives align with ApexBrasil's focus on expanding Brazilian exports and attracting investments in high-value sectors.
Key details
ApexBrasil, the Brazilian Agency for the Promotion of Exports and Investments, unveiled a new digital panel to expand Brazilian export opportunities within the European Union, aiming especially to assist micro, small, and medium-sized enterprises. Launched during the 'Conexões Produtivas – Opportunities for Industry in the Mercosul-European Union Agreement' event in São Paulo, this tool maps 543 immediate tariff reduction opportunities across 25 European countries, primarily in sectors like food, machinery, chemicals, and manufactured goods. The platform offers a detailed state-by-state view, helping companies identify products with high export potential to Europe, alongside data on tariff reduction timelines and demand trends. Vice President Geraldo Alckmin highlighted that the focus is now on ensuring Brazilian firms can fully capitalize on the trade agreement benefits, with the EU standing as Brazil's second-largest trading partner, representing about $100 billion in annual trade and nearly half of foreign direct investments in Brazil.
Simultaneously, Brazil reinforced its stature in global health innovation by participating in the BIO International Convention 2026 in San Diego, where more than 70 Brazilian companies and 200 representatives showcased the nation's robust biotechnology and pharmaceutical sectors. This participation, coordinated by ApexBrasil alongside the Brazilian Pharmaceutical Industry Association (Abiquifi), featured strategic business meetings and events such as the XI Summit Brazil and the Invest in Brazil | One Health Summit, emphasizing innovations, regulatory enhancements, and investment attraction. Débora Lima from ApexBrasil noted the convention as a pivotal platform for demonstrating Brazil's health innovation capabilities and fostering international partnerships.
These efforts underscore ApexBrasil's dual approach to expanding Brazil's international trade footprint — through enhanced export facilitation to the EU and active promotion in high-value sectors like biotechnology, signaling a confident push toward greater global integration and economic growth for Brazilian companies.
This article was translated and synthesized from Brazilian sources, providing English-speaking readers with local perspectives.
